Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Derrick

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1994
Antibodies to GPIIb alpha (300-312) inhibit Fg binding, clot retraction, and platelet adhesion to multiple ligandsD B Taylor, J M Derrick, T K Gartner
Thrombosis Research|June 4, 1998
Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape changeJ M Derrick, R G Loudon, T K Gartner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Characterization of adhesion of non-exogenously stimulated and resting platelets in normal plasma to fibrinogen and its fragmentsT K Gartner, D L Amrani, J M Derrick
The Biochemical Journal|July 15, 1997
The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin alphaIIbbeta3J M Derrick, D B Taylor, R G Loudon, et al.
Thrombosis and Haemostasis|October 5, 2001
Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptideJ M Derrick, S J Shattil, M Poncz, et al.
Thrombosis Research|July 1, 1993
Characterization of adhesion of "resting" and stimulated platelets to fibrinogen and its fragmentsT K Gartner, D L Amrani, J M Derrick, et al.
Blood|December 23, 1999
A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3R B Basani, D L French, G Vilaire, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1994
Antibodies to GPIIb alpha (300-312) inhibit Fg binding, clot retraction, and platelet adhesion to multiple ligandsD B Taylor, J M Derrick, T K Gartner
Thrombosis Research|June 4, 1998
Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape changeJ M Derrick, R G Loudon, T K Gartner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Characterization of adhesion of non-exogenously stimulated and resting platelets in normal plasma to fibrinogen and its fragmentsT K Gartner, D L Amrani, J M Derrick
The Biochemical Journal|July 15, 1997
The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin alphaIIbbeta3J M Derrick, D B Taylor, R G Loudon, et al.
Thrombosis and Haemostasis|October 5, 2001
Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptideJ M Derrick, S J Shattil, M Poncz, et al.
Thrombosis Research|July 1, 1993
Characterization of adhesion of "resting" and stimulated platelets to fibrinogen and its fragmentsT K Gartner, D L Amrani, J M Derrick, et al.
Blood|December 23, 1999
A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3R B Basani, D L French, G Vilaire, et al.
Pageof 1